Jason A. Clemens, former Chief Financial Officer of AdaptHealth Corp., filed a Form 144 notice on November 13, 2026, proposing the sale of 10,000 shares of AdaptHealth common stock through Morgan Stanley Smith Barney LLC.
Key Highlights
- Proposed sale: 10,000 shares of AdaptHealth Corp. common stock with an aggregate market value of $77,335.00, according to the filing.
- Seller: Jason A. Clemens, identified in the filing as former CFO of AdaptHealth Corp.
- Approximate sale date: November 13, 2026, via Morgan Stanley Smith Barney LLC Executive Financial Services in New York.
- Shares outstanding: The filing reports 136,525,348 shares of common stock outstanding.
- Acquisition history: The shares to be sold were acquired through restricted stock vesting under a registered plan, with 3,070 shares vesting on October 1, 2022, and 6,930 shares vesting on January 1, 2023, both for services rendered.
- Recent sales: Clemens sold 169,779 shares on November 5, 2026 (gross proceeds $1,260,743.41), 60,978 shares on November 6, 2026 (gross proceeds $447,510.44), and 19,855 shares on November 11, 2026 (gross proceeds $154,712.15) in the three months prior to this notice.
Clemens Proposes Additional AdaptHealth Common Stock Sale Following Recent Transactions
AdaptHealth Corp. (NASDAQ:AHCO) former CFO Jason A. Clemens filed a Form 144 notice of proposed sale of securities with the U.S. Securities and Exchange Commission on November 13, 2026. The filing discloses Clemens's intent to sell 10,000 shares of AdaptHealth common stock, with an aggregate market value listed as $77,335.00. The proposed sale is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, on or around November 13, 2026, on the NASDAQ exchange.
According to the filing, the shares proposed for sale were acquired through restricted stock vesting under a registered plan from the issuer: 3,070 shares on October 1, 2022, and 6,930 shares on January 1, 2023, in both cases as payment for services rendered. AdaptHealth Corp. is listed as the issuer, with its address at 555 East North Lane, Suite 5075, Conshohocken, Pennsylvania 19428, and SEC File Number 001-38399.
The filing also discloses that Clemens sold shares of AdaptHealth common stock on three occasions in the three months preceding this notice: 169,779 shares on November 5, 2026 (gross proceeds of $1,260,743.41); 60,978 shares on November 6, 2026 (gross proceeds of $447,510.44); and 19,855 shares on November 11, 2026 (gross proceeds of $154,712.15). By signing the notice, Clemens represented, as stated in the filing, that he "does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed."
What Was Disclosed
A Form 144 notice was filed on November 13, 2026, by former AdaptHealth CFO Jason A. Clemens, disclosing a proposed sale of 10,000 shares of AdaptHealth common stock valued at $77,335.00, alongside three prior sales totaling approximately $1,862,956.00 in gross proceeds over the previous eight days.



Please wait processing your request...